PTBP2-Mediated Alternative Splicing of IRF9 Controls Tumor-Associated Monocyte/Macrophage Chemotaxis and

Jue Tang1, Jing He1, Huiqin Guo1,2

  • 1Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, Guangdong, China.

Insights

Polypyrimidine tract binding protein 2 (PTBP2) in neuroblastoma (NB) cells attracts monocytes and macrophages, inhibiting tumor growth. This PTBP2-induced immune response predicts a favorable prognosis in mediastinal NB.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Mediastinal neuroblastoma (NB) recurrence and metastasis remain significant challenges post-treatment.
  • Tumor microenvironment modulation shows promise, yet the roles of monocytes and macrophages in NB are underexplored.

Purpose of the Study:

  • To investigate the role of polypyrimidine tract binding protein 2 (PTBP2) in mediastinal NB.
  • To elucidate the mechanisms by which PTBP2 influences the tumor microenvironment, specifically monocytes and macrophages.

Main Methods:

  • Proteomic profiling to identify potential biomarkers in mediastinal NB.
  • Functional studies assessing the impact of PTBP2 on monocyte/macrophage activity and NB progression.
  • Mechanistic investigations involving RNA splicing, interferon signaling, and chemokine secretion.

Main Results:

  • PTBP2 was identified as a potential biomarker in mediastinal NB, correlating with good outcomes.
  • PTBP2 expression in NB cells promoted monocyte and macrophage chemotaxis and repolarization, inhibiting tumor growth and metastasis.
  • PTBP2 was found to regulate interferon regulatory factor 9 splicing and enhance type I interferon secretion via STAT1 and CCL5, driving monocyte/macrophage recruitment and maintaining a proinflammatory phenotype.

Conclusions:

  • PTBP2 plays a critical role in modulating the immune microenvironment in NB by influencing monocyte and macrophage functions.
  • PTBP2-mediated RNA splicing enhances immune compartmentalization between NB cells and monocytes, contributing to a favorable prognosis.
  • PTBP2 represents a potential therapeutic target and prognostic marker for mediastinal neuroblastoma.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.6K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.5K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K